Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Sponsors and Collaborators

GlaxoSmithKline 

Contact

US GSK Clinical Trials Call Center 


Continue Reading

877-379-3718

GSKClinicalSupportHD@gsk.com 

Investigators
GSK Clinical Trials
GlaxoSmithKline
  

ClinicalTrials.gov Identifier

NCT00424255